In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Panthera On The SMO Model, Responsible Growth Priorities And The Hybridized Trial Of The Future

Executive Summary

In this episode of the In Vivo podcast, Jo Shorthouse speaks with the co-founder and chief commercial officer of the site management organization, Panthera Biopartners. The discussion centers on the practicalities and reality of running clinical trial sites as a business, and the age-old challenge of patient recruitment.

With recommendations coming from the EU this past December on decentralized clinical trials, the clinical research industry is still attempting to find global harmonization that would lead trial modernization.

Many clinical trials cannot, for logistical reasons, be fully decentralized, that is the view of Panthera Biopartners’ Ian Smith and Chris Dodd, who talk with In Vivo about the decentralized and hybridized trial model, and where efficiencies can be found along the clinical trial pathway.

Also up for discussion is the efficiencies found with the SMO model, and how the firm is funding its future responsibly.


Time stamps:

1:45 The Panthera Model

5:15 The SMO Approach To Study Set Up

14:00 A Data Approach To Patient Recruitment And Retention

18: 46 Decentralized Trials

21:20 The hybridized trial model

25:45 Growth priorities and moving to a tactical partnership model

27:00 Responsible growth


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts